Search

everythinglearnresearchcommunity

for

Search:↓

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Ruxolitinib can cause a delayed skin reaction on the nose.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.